12 results
8-K
EX-99.1
LUMO
Lumos Pharma Inc
4 Jan 24
Regulation FD Disclosure
4:34pm
impressive academic tenure at the Keck School of Medicine, University of Southern California, Children Hospital Los Angeles and his over 12-year presidency
8-K
EX-99.1
LUMO
Lumos Pharma Inc
2 Aug 21
Lumos Pharma Announces the Promotion of COO and Chief Scientific Officer, John McKew, PhD, to President
9:22am
for nearly ten years at both Lumos and, prior to that, in a collaboration during his tenure at the NIH. Our interactions over this period and John’s
8-K
EX-99.1
LUMO
Lumos Pharma Inc
21 Apr 21
Lumos Pharma Announces Retirement of Carl Langren and Names Lori Lawley Chief Financial Officer in Planned Succession
4:36pm
responsibility, advancing to Vice President of Finance and member of NewLink’s Office of the CEO in 2018. Prior to her tenure with the Company, Ms
8-K
EX-99.1
LUMO
Lumos Pharma Inc
24 Apr 20
Other Events
10:04am
to build an integrated, late stage company based on a protein engineering platform with utility in rare disease and cancer. Throughout his tenure
DEFA14A
EX-99.1
LUMO
Lumos Pharma Inc
30 Sep 19
Additional proxy soliciting materials
12:00am
cofounder, Nick Vahanian, for the insight and relentless energy he brought to the company throughout his tenure. The Board thanks Dr. Vahanian
8-K
EX-99.1
f5rq3hv 7h64s66r9bst
30 Sep 19
Entry into a Material Definitive Agreement
12:00am
DEFA14A
EX-3.1
mp0s21cf j05
30 Sep 19
Additional proxy soliciting materials
12:00am
8-K
EX-3.1
ad4iaqp0vu15kqer
30 Sep 19
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.1
eropk8bedaom4rv
1 May 18
NewLink Genetics Appoints Matthew L. Sherman, M.D. to Board of Directors
9:11am
8-K
slnwdi9m
1 May 18
NewLink Genetics Appoints Matthew L. Sherman, M.D. to Board of Directors
9:11am
8-K
EX-99.1
eworo oyk93sc
1 Oct 14
NewLink Genetics Corporation Announces Appointment of New Executive Vice President and Chief Financial Officer
12:00am
8-K
EX-3.2
5ac ydpbe7honw
18 Nov 11
Entry into a Material Definitive Agreement
12:00am
- Prev
- 1
- Next